Capillaroscopic insights: exploring the connection between microvascular changes and pulmonary manifestations in systemic sclerosis

1. DERK C.T., JIMENEZ S.A. Systemic sclerosis: current views of its pathogenesis. Autoimmun. Rev. 2003; 2:181–191 DERKC.T JIMENEZS.A Systemic sclerosis: current views of its pathogenesis Autoimmun. Rev 2003 2 181 191 Search in Google Scholar

2. HERRICK A.L., MATUCCI CERINIC M. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin. Exp. Rheumatol. 2001; 19:4–8 HERRICKA.L MATUCCI CERINICM The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis Clin. Exp. Rheumatol. 2001 19 4 8 Search in Google Scholar

3. ASSASSI S., MAYES M.D., ARNETT F.C., GOURH P., AGARWAL S.K., MCNEARNEY T.A., et al. Systemic sclerosis and lupus: Points in an interferon‐mediated continuum. Arthritis Rheum. 2010; 62:589–598 ASSASSIS MAYESM.D ARNETTF.C GOURHP AGARWALS.K MCNEARNEYT.A Systemic sclerosis and lupus: Points in an interferon‐mediated continuum Arthritis Rheum 2010 62 589 598 Search in Google Scholar

4. DOMSIC R.T. Scleroderma. Curr. Opin. Rheumatol. 2014; 26:646–652 DOMSICR.T Scleroderma Curr. Opin. Rheumatol 2014 26 646 652 Search in Google Scholar

5. SMITH V., DECUMAN S., SULLI A., BONROY C., PIETTTE Y., DESCHEPPER E., et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann. Rheum. Dis. 2012; 71:1636–1639 SMITHV DECUMANS SULLIA BONROYC PIETTTEY DESCHEPPERE Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study Ann. Rheum. Dis 2012 71 1636 1639 Search in Google Scholar

6. ELSAYED A.M., ELHEFNY A.M., ABOGABAL M.M., MOBASHER S.A., ABDELZAHER A., ALHASSANEIN K.F., et al. Progressive systemic sclerosis in Egyptian patients: Clinical characteristics and nail fold capillaroscopy. Egypt. Rheumatol. 2019; 41:47–51 ELSAYEDA.M ELHEFNYA.M ABOGABALM.M MOBASHERS.A ABDELZAHERA ALHASSANEINK.F Progressive systemic sclerosis in Egyptian patients: Clinical characteristics and nail fold capillaroscopy Egypt. Rheumatol 2019 41 47 51 Search in Google Scholar

7. MEIJS J., SCHOUFFOER A.A., AJMONE MARSAN N., KROFT L.J.M., STIJNEN T., NINABER M.K., et al. Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis. RMD Open 2016; 2:e000159 MEIJSJ SCHOUFFOERA.A AJMONE MARSANN KROFTL.J.M STIJNENT NINABERM.K Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis RMD Open 2016 2 e000159 Search in Google Scholar

8. PRESTON I.R., HILL N.S. Evaluation and management of pulmonary hypertension in systemic sclerosis. Curr. Opin. Rheumatol. 2003; 15:761–765 PRESTONI.R HILLN.S Evaluation and management of pulmonary hypertension in systemic sclerosis Curr. Opin. Rheumatol 2003 15 761 765 Search in Google Scholar

9. BEHR J., VOGELMEIER C., BEINERT T., MEURER M., KROMBACH F., KÖNIG G., et al. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am. J. Respir. Crit. Care Med. 1996; 154:400–406 BEHRJ VOGELMEIERC BEINERTT MEURERM KROMBACHF KÖNIGG Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung Am. J. Respir. Crit. Care Med. 1996 154 400 406 Search in Google Scholar

10. TYNDALL A.J., BANNERT B., VONK M., AIRO P., COZZI F., CARREIRA P.E., et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann. Rheum. Dis. 2010; 69:1809–1815 TYNDALLA.J BANNERTB VONKM AIROP COZZIF CARREIRAP.E Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database Ann. Rheum. Dis 2010 69 1809 1815 Search in Google Scholar

11. MUKERJEE D. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann. Rheum. Dis. 2003; 62:1088–1093 MUKERJEED Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach Ann. Rheum. Dis 2003 62 1088 1093 Search in Google Scholar

12. DEMEROUTI E., TSANGARIS I., DIMITROULAS T., GIANNAKOULAS G., KATSIMPRI P., MITROUSKA I., et al. Pulmonary Arterial Hypertension in Connective Tissue Disorders: The emerging role of screening and early diagnosis. A position paper for Greek Rheumatologists. Mediterr. J. Rheumatol. 2019; 30:90–93 DEMEROUTIE TSANGARISI DIMITROULAST GIANNAKOULASG KATSIMPRIP MITROUSKAI Pulmonary Arterial Hypertension in Connective Tissue Disorders: The emerging role of screening and early diagnosis. A position paper for Greek Rheumatologists Mediterr. J. Rheumatol. 2019 30 90 93 Search in Google Scholar

13. INGEGNOLI F., ARDOINO I., BORACCHI P., CUTOLO M., AIRÒ P., ANANIEVA L.P., et al. Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database. Microvasc. Res. 2013; 89:122–128 INGEGNOLIF ARDOINOI BORACCHIP CUTOLOM AIRÒP ANANIEVAL.P Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database Microvasc. Res 2013 89 122 128 Search in Google Scholar

14. HERRICK A.L., CUTOLO M. Clinical implications from capillaroscopic analysis in patients with Raynaud’s phenomenon and systemic sclerosis. Arthritis Rheum. 2010; 62:2595–2604 HERRICKA.L CUTOLOM Clinical implications from capillaroscopic analysis in patients with Raynaud’s phenomenon and systemic sclerosis Arthritis Rheum 2010 62 2595 2604 Search in Google Scholar

15. VAN DEN HOOGEN F., KHANNA D., FRANSEN J., JOHNSON S.R., BARON M., TYNDALL A., et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann. Rheum. Dis. 2013; 72:1747–1755 VAN DEN HOOGENF KHANNAD FRANSENJ JOHNSONS.R BARONM TYNDALLA 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative Ann. Rheum. Dis 2013 72 1747 1755 Search in Google Scholar

16. VASILE M., AVOUAC J., SCIARRA I., STEFANANTONI K., IANNACE N., CRAVOTTO E., et al. From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey. Clin. Exp. Rheumatol. 2018; 36 Suppl 1:82–87 VASILEM AVOUACJ SCIARRAI STEFANANTONIK IANNACEN CRAVOTTOE From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey Clin. Exp. Rheumatol. 2018 36 Suppl 1 82 87 Search in Google Scholar

17. CUTOLO M., MELSENS K., WIJNANT S., INGEGNOLI F., THEVISSEN K., DE KEYSER F., et al. Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal. Autoimmun. Rev. 2018; 17:344–352 CUTOLOM MELSENSK WIJNANTS INGEGNOLIF THEVISSENK DE KEYSERF Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal Autoimmun. Rev 2018 17 344 352 Search in Google Scholar

18. MEDSGER T.A., BOMBARDIERI S., CZIRJAK L., SCORZA R., DELLA ROSSA A., BENCIVELLI W. Assessment of disease severity and prognosis. Clin. Exp. Rheumatol. 2003; 21:S42-6 MEDSGERT.A BOMBARDIERIS CZIRJAKL SCORZAR DELLA ROSSAA BENCIVELLIW Assessment of disease severity and prognosis Clin. Exp. Rheumatol. 2003 21 S42-6 Search in Google Scholar

19. INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES. Cardiovascular Disability: Updating the Social Security Listings, The National Academies Press, Washington, DC, 2010 INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES Cardiovascular Disability: Updating the Social Security Listings The National Academies Press Washington, DC 2010 Search in Google Scholar

20. PATTANAIK D., BROWN M., POSTLETHWAITE B.C., POSTLETHWAITE A.E. Pathogenesis of Systemic Sclerosis. Front. Immunol. 2015; 6:272 PATTANAIKD BROWNM POSTLETHWAITEB.C POSTLETHWAITEA.E Pathogenesis of Systemic Sclerosis Front. Immunol. 2015 6 272 Search in Google Scholar

21. CUTOLO M., SULLI A., SMITH V. How to perform and interpret capillaroscopy. Best Pract. Res. Clin. Rheumatol. 2013; 27:237–248 CUTOLOM SULLIA SMITHV How to perform and interpret capillaroscopy Best Pract. Res. Clin. Rheumatol 2013 27 237 248 Search in Google Scholar

22. SULLI A., PIZZORNI C., SMITH V., ZAMPOGNA G., RAVERA F., CUTOLO M. Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum. 2012; 64:821–825 SULLIA PIZZORNIC SMITHV ZAMPOGNAG RAVERAF CUTOLOM Timing of transition between capillaroscopic patterns in systemic sclerosis Arthritis Rheum 2012 64 821 825 Search in Google Scholar

23. MOORE D.F., STEEN V.D. Overall mortality. J. Scleroderma Relat. Disord. 2021; 6:3–10 MOORED.F STEENV.D Overall mortality J. Scleroderma Relat. Disord 2021 6 3 10 Search in Google Scholar

24. WALKER U.A., TYNDALL A., CZIRJAK L., DENTON C., FARGE-BANCEL D., KOWAL-BIELECKA O., et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann. Rheum. Dis. 2007; 66:754–763 WALKERU.A TYNDALLA CZIRJAKL DENTONC FARGE-BANCELD KOWAL-BIELECKAO Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database Ann. Rheum. Dis 2007 66 754 763 Search in Google Scholar

25. RAHAGHI F.F., HSU V.M., KANER R.J., MAYES M.D., ROSAS I.O., SAGGAR R., et al. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir. Res. 2023; 24:6 RAHAGHIF.F HSUV.M KANERR.J MAYESM.D ROSASI.O SAGGARR Expert consensus on the management of systemic sclerosis-associated interstitial lung disease Respir. Res. 2023 24 6 Search in Google Scholar

26. COGHLAN J.G., DENTON C.P., GRÜNIG E., BONDERMAN D., DISTLER O., KHANNA D., et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann. Rheum. Dis. 2014; 73:1340–1349 COGHLANJ.G DENTONC.P GRÜNIGE BONDERMAND DISTLERO KHANNAD Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study Ann. Rheum. Dis 2014 73 1340 1349 Search in Google Scholar

27. VOLKMANN E.R., FISCHER A. Update on morbidity and mortality in systemic sclerosis–related interstitial lung disease. J. Scleroderma Relat. Disord. 2021; 6:11–20 VOLKMANNE.R FISCHERA Update on morbidity and mortality in systemic sclerosis–related interstitial lung disease J. Scleroderma Relat. Disord 2021 6 11 20 Search in Google Scholar

28. GUALTIEROTTI R., INGEGNOLI F., GRIFFINI S., GROVETTI E., BORGHI M.O., BUCCIARELLI P., et al. Detection of early endothelial damage in patients with Raynaud’s phenomenon. Microvasc. Res. 2017; 113:22–28 GUALTIEROTTIR INGEGNOLIF GRIFFINIS GROVETTIE BORGHIM.O BUCCIARELLIP Detection of early endothelial damage in patients with Raynaud’s phenomenon Microvasc. Res 2017 113 22 28 Search in Google Scholar

29. CESTELLI V., MANFREDI A., SEBASTIANI M., PRAINO E., CANNARILE F., GIUGGIOLI D., et al. Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis. Mod. Rheumatol. 2017; 27:110–114 CESTELLIV MANFREDIA SEBASTIANIM PRAINOE CANNARILEF GIUGGIOLID Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis Mod. Rheumatol 2017 27 110 114 Search in Google Scholar